The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Open accessAbstract
The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.
Key findings
- Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
- BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
- A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
- In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.
Methods
- The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
- The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.
Limitations
- The paper’s abstract does not state limitations.
- Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Own interpretation · 4 Own result · 2 No full text of the sources · 1 No basis given
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is present in the surviving T cells in the thymic medulla.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A limited number of nonlymphoid tissues demonstrate BCL2”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glandular epithelium in which hormones or growth factors regulate hyperplasia and involution”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“long-lived postmitotic cells such as neurons”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
In the paper
“Transgenic mice that overexpress BCL2 display extended survival of resting B cells.”
What the sources say
- Not checked — no full text of the sourcecites McDonnell et al., 1989 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
- It may state two separate claims as one. 1
In the paper
“The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
What the sources say
- Not checked — no full text of the sourcecites Hockenbery et al., 1990 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The anti-human BCL2 antibody used in this study is monospecific for BCL2.
“we use a monospecific anti-human BCL2 antibody”
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
Cheng, H., & Leblond, C. P. (1974) · American Journal of Anatomy · doi:10.1002/aja.1001410407 · Cited by 1,737
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cohen, J., & Duke, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.38 · Cited by 1,406
Regressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citationCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,177
Self-citation
Cited by
Sorted by citations
Items 101–200 of 1,244
Burger, P. E., Xiong, X., Coetzee, S., Salm, S. N., Moscatelli, D., Goto, K., & Wilson, E. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502761102 · Cited by 266
BCL‐2 expression in adult and embryonic non‐haematopoietic tissues
Lu, Q., Poulsom, R., Wong, L., & Hanby, A. M. (1993) · The Journal of Pathology · doi:10.1002/path.1711690408 · Cited by 261
Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed Central · Cited by 253
Apoptosis in human skin development: Morphogenesis, periderm, and stem cells
Polakowska, R. R., Piacentini, M., Bartlett, R., Goldsmith, L. A., & Haake, A. R. (1994) · Developmental Dynamics · doi:10.1002/aja.1001990303 · Cited by 250
Weller, M., Malipiero, U., Aguzzi, A., Reed, J. C., & Fontana, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117965 · Cited by 250
Linette, G. P., Grusby, M. J., Hedrick, S. Μ., Hansen, T. H., Glimcher, L. H., & Korsmeyer, S. J. (1994) · Immunity · doi:10.1016/1074-7613(94)90098-1 · Cited by 248
Self-citationNeuroendocrine cells in tumour growth of the prostate.
Abrahamsson, P. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060503 · Cited by 247
“The bcl-2 proto-oncogene prevents apoptosis and is expressed by prostatic basal cells that are known to be androgen independent (Hockenbery et al. 1991).”
BackgroundExpression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Bclx regulates the survival of double-positive thymocytes.
Ma, A. I., Pena, J. C., Chang, B. S., Margosian, E., Davidson, L., Alt, F. W., & Thompson, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4763 · Cited by 243
Ci, W., Polo, J. M., Cerchietti, L. C. A., Shaknovich, R., Wang, L., Yang, S. N., Ye, K. Q., Farinha, P., Horsman, D. E., Gascoyne, R. D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-193037 · Cited by 251
Apoptotic versus proliferative activities in human benign prostatic hyperplasia
Kyprianou, N., Tu, H., & Jacobs, S. C. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90396-2 · Cited by 235
Keratinocyte Apoptosis in Epidermal Development and Disease
Raj, D., Brash, D. E., & Grossman, D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700008 · Cited by 246
“For example, basal KCs are protected from apoptosis by expression of Bcl-2, which is absent from suprabasal KCs (Hockenbery et al., 1991), and a gradient of Bak expression increases from lower to upper layers to promote cell death (Krajewski et al.”
BackgroundThe role of free radicals and p53 in neuron apoptosis in vivo
Wood, K., & Youle, R. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05851.1995 · Cited by 235
Ray, S. K., Putterman, C., & Diamond, B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2019 · Cited by 232
Shaham, S., & Horvitz, H. R. (1996) · Genes & Development · doi:10.1101/gad.10.5.578 · Cited by 232
“Both ced-9 and ced-3 have known mammalian counterparts that function in cell death, ced-9 encodes a protein similar in sequence to the human proto-oncoprotein Bcl-2 (Hengartner and Horvitz 1994a), which like the CED-9 protein can protect cells from programmed cell death (Vaux et al. 1988; Nunez et al. 1990; Hockenbery…”
BackgroundHolmin, S., & Mathiesen, T. I. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.92.1.0108 · Cited by 230
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
Herod, J., Eliopoulos, A. G., Warwick, J., Niedobitek, G., Young, L. S., & Kerr, R. S. (1996) · PubMed · doi:10.82444/warw.33646729 · Cited by 229
Böhm, M., Wolff, I., Scholzen, T. E., Robinson, S. J., Healy, E., Luger, T. A., Schwarz, T., & Schwarz, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406334200 · Cited by 228
Primary cutaneous follicle center cell lymphoma with follicular growth pattern
Cerroni, L., Arzberger, E. J., Pütz, B., et al. (2000) · Blood · doi:10.1182/blood.v95.12.3922 · Cited by 227
Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas.
Leoncini, L., Vecchio, M. T. D., Megha, T., et al. (1993) · PubMed · Cited by 224
BCL-2 as therapeutic target for hematological malignancies
Perini, G. F., Ribeiro, G., Neto, J. V. P., Campos, L. T., & Hamerschlak, N. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0608-2 · Cited by 227
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence
Lewis, J., Wesselingh, S. L., Griffin, D. E., & Hardwick, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1828-1835.1996 · Cited by 223
Body mass and breast cancer: Relationship between method of detection and stage of disease
Reeves, M. J., Newcomb, P. A., Remington, P., Marcus, P. M., & Kenzie, W. R. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2 · Cited by 73
The Protooncogene bcl‐2 Inhibits Apoptosis in PC12 Cells
Mah, S. P., Zhong, L. T., Liu, Y., et al. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03275.x · Cited by 219
Martínez-Valdez, H., Guret, C., de Bouteiller, O., Fugier, I., Banchereau, J., & Liu, Y. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.971 · Cited by 217
Bax promotes neuronal cell death and is downregulated during the development of the nervous system
Vekrellis, K., McCarthy, M. J., Watson, A., et al. (1997) · Development · doi:10.1242/dev.124.6.1239 · Cited by 213
BCL2 Overexpression Associated With Chromosomal Amplification in Diffuse Large B-Cell Lymphoma
Monni, O. M., Joensuu, H., Franssila, K., Klefström, J. T., Alitalo, K. K., & Knuutila, S. (1997) · Blood · doi:10.1182/blood.v90.3.1168 · Cited by 212
Ultraviolet radiation-induced apoptosis in keratinocytes: On the role of cytosolic factors
Assefa, Z., Van Laethem, A., Garmyn, M., & Agostinis, P. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.001 · Cited by 212
Hematopoietic growth factors and their receptors in acute leukemia
Löwenberg, B., & Touw, I. P. (1993) · Blood · doi:10.1182/blood.v81.2.281.281 · Cited by 210
Uckan, D. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.8.655 · Cited by 206
“Bcl-2 is expressed and appears to act as a survival factor in fetal tissues and in a restricted manner in some adult tissues characterized by apoptotic cell death (Hockenbery et al., 1991; Baer, 1994).”
Backgroundc-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.
Ryan, J. J., Prochownik, E. V., Gottlieb, C. A., Apel, I. J., Merino, R., Núñez, G., & Clarke, M. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5878 · Cited by 208
Grossman, D., Kim, P. J., Blanc‐Brude, O., Brash, D. E., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13345 · Cited by 204
“A similar transgenic strategy has been used in the past to investigate the contribution of bcl-2 family members (27, 28), and p53 regulators (29) in epidermal proliferation, differentiation, and apoptosis.”
BackgroundThe bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.
Bronner, M. P., Culin, C., Reed, J. C., & Furth, E. E. (1995) · PubMed Central · Cited by 203
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D. S. G., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
“It is worth noting that human T cells and epithelial cells can under certain circumstances express Bcl-2 (1, 2, 22) and that the inability of LMP1 to upregulate the cellular oncogene in these cell types does not therefore reflect an inherent inability to express Bcl-2.”
BackgroundThe role of cytosolic Ca2+ in cell injury, necrosis and apoptosis
Trump, B. F., & Berezesky, I. K. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90037-d · Cited by 198
Columbano, A. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240580207 · Cited by 194
Falini, B., & Mason, D. Y. (2002) · Blood · doi:10.1182/blood.v99.2.409 · Cited by 193
Neilan, J. G., Lu, Z., Afonso, C. L., Kutish, G. F., Sussman, M. D., & Rock, D. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4391-4394.1993 · Cited by 195
Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.
Wrone-Smith, T., Mitra, R. S., Thompson, C. B., Jasty, R., Castle, V. P., & Nickoloff, B. J. (1997) · Europe PMC (PubMed Central) · Cited by 194
Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma
Lu, Q., Elia, G., Lucas, S. B., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530107 · Cited by 194
Verborgt, O., Tatton, N. A., Majeska, R. J., & Schaffler, M. B. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.907 · Cited by 192
Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
Charlotte, F., L’Herminé, A. C., Martin, N., Geleyn, Y., Nollet, M., Gaulard, P., & Zafrani, E. (1994) · PubMed Central · Cited by 188
Young, R. L., & Korsmeyer, S. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3686 · Cited by 187
Self-citationJones, B. A., & Gores, G. J. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.6.g1174 · Cited by 187
Carayon, P., Portier, M., Dussossoy, D., Bord, A., Petitpretre, G., Canat, X., Fur, G. L., & Casellas, P. (1996) · Blood · doi:10.1182/blood.v87.8.3170.bloodjournal8783170 · Cited by 187
Prognostic value of bcl-2 expression in invasive breast cancer
Hellemans, P., van Dam, P., Weyler, J., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.338 · Cited by 187
Chopp, M., Li, Y., Jiang, N., Zhang, R. L., & Prostak, J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199607000-00007 · Cited by 185
Huang, H., Cheville, J. C., Pan, Y., Roche, P. C., Schmidt, L. J., & Tindall, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103632200 · Cited by 185
Paradoxical inhibition of solid tumor cell growth by bcl2.
Pietenpol, J. A., Papadopoulos, N., Markowitz, S. D., et al. (1994) · PubMed · Cited by 185
A dominant interfering Myb mutant causes apoptosis in T cells.Preprint
Taylor, D., Badiani, P., & Weston, K. (1996) · Genes & Development · doi:10.1101/gad.10.21.2732 · Cited by 183
Selvakumaran, M., Lin, H., Sjin, R. T. T., Reed, J. C., Liebermann, D. A., & Hoffman‐Liebermann, B. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2352 · Cited by 183
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice.
Siegel, R. M., Katsumata, M., Miyashita, T., Louie, D. C., Greene, M. I., & Reed, J. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7003 · Cited by 179
Saile, B., Knittel, T. E., Matthes, N., Schott, P., & Ramadori, G. P. (1997) · Europe PMC (PubMed Central) · Cited by 177
MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies
Tsuboi, K., Iida, S., Inagaki, H., Kato, M., Hayami, Y., Hanamura, I., Miura, K., Harada, S., Kikuchi, M., Komatsu, H., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401696 · Cited by 177
Payne, C. M., Bernstein, C., & Bernstein, H. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059662 · Cited by 174
BCL-2 in prostate cancer: A minireview
Catz, S. D., & Johnson, J. L. (2003) · APOPTOSIS · doi:10.1023/a:1021692801278 · Cited by 178
Deng, G., & Podack, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2189 · Cited by 173
Borsellino, N., Belldegrun, A. S., & Bonavida, B. (1995) · PubMed · Cited by 172
Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
Chan, W. Y., Cheung, K., Schorge, J. O., Huang, L., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64744-x · Cited by 175
NEUROTROPHIN-3 EXPRESSION IN HUMAN PANCREATIC CANCERS
Ohta, T., Numata, M., Tsukioka, Y., Futagami, F., Kayahara, M., Kitagawa, H., Nagakawa, T., Yamamoto, M., WAKAYAMA, T., Kitamura, Y., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199704)181:4 · Cited by 34
Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats
Arai, Y., Sekine, Y., & Murakami, S. (1996) · Neuroscience Research · doi:10.1016/0168-0102(96)01070-x · Cited by 169
Morimitsu, Y., Nakajima, M., Hisaoka, M., & Hashimoto, H. (2000) · Apmis · doi:10.1034/j.1600-0463.2000.d01-105.x · Cited by 167
Karsan, A., Yee, E., Kaushansky, K., & Harlan, J. (1996) · Blood · doi:10.1182/blood.v87.8.3089.bloodjournal8783089 · Cited by 172
Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer
Ismail, N. I., Othman, I., Abas, F., Lajis, N. H., & Naidu, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102454 · Cited by 180
Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas
Jiang, S., Sato, Y., Kuwao, S., & Kameya, T. (1995) · The Journal of Pathology · doi:10.1002/path.1711770206 · Cited by 165
Mechanisms controlling cellular suicide: role of Bcl-2 and caspases
Allen, R. T., Cluck, M. W., & Agrawal, D. K. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050171 · Cited by 166
Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms
Zutter, M. M., Hockenbery, D. M., Silverman, G. A., et al. (1991) · Blood · doi:10.1182/blood.v78.4.1062.1062 · Cited by 166
Self-citationbcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas
Bòsari, S., Moneghini, L., Graziani, D. M. G., et al. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90250-3 · Cited by 165
Small cell carcinomas of the lung express the Bcl-2 protein.
Ben‐Ezra, J. M., Kornstein, M. J., Grimes, M., & Krystal, G. (1994) · PubMed Central · Cited by 164
Campos, L., Sabido, O., Rouault, J., et al. (1994) · Blood · doi:10.1182/blood.v84.2.595.595 · Cited by 164
The Development of Functionally Responsive T Cells
Rothenberg, E. V. (1992) · Advances in immunology · doi:10.1016/s0065-2776(08)60487-3 · Cited by 160
Bcl-2 protein expression during murine development.
Novack, D. V., & Korsmeyer, S. J. (1994) · PubMed · Cited by 162
Self-citationApoptosis and cancer: the failure of controls on cell death and cell survival
Martin, S. J., & Green, D. R. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00124-c · Cited by 160
Selected genetic factors associated with male infertility
Huynh, T. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.2.183 · Cited by 161
“Bcl-2 is present only in mature sperm and not in the seminiferous epithelium (Hockenbery et al., 1991) whilst Mcl-1 (a further prosurvival member of the Bcl-2 subfamily) is restricted to Leydig cells (Krajewski et al., 1995).”
BackgroundShen, D. F., Zhuang, Z., LeHoang, P., et al. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)99036-4 · Cited by 160
Estrov, Z. E., Talpaz, M., Zipf, T. F., Kantarjian, H. M., Ku, S., Ouspenskaia, M. V., Hirsch‐Ginsberg, C., Huh, Y. O., Yee, G., & Kurzrock, R. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199603)166:3 · Cited by 30
Huerta, S., Goulet, E. J., & Livingston, E. H. (2006) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2005.11.009 · Cited by 157
“[34] Hockenbery DM, Zutter M, Hickey W, et al.”
BackgroundApoptotic Protease Activating Factor 1 (Apaf-1)–Independent Cell Death Suppression by Bcl-2
Haraguchi, M., Torii, S., Matsuzawa, S., Xie, Z., Kitada, S., Krajewski, S., Yoshida, H., Mak, T. W., & Reed, J. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1709 · Cited by 158
Yan, W., Samson, M., Jégou, B., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.5.682 · Cited by 157
Zhou, P., Qian, L., Bieszczad, C. K., Noelle, R. J., Binder, M., Levy, N. B., & Craig, R. W. (1998) · Blood · doi:10.1182/blood.v92.9.3226 · Cited by 156
Intestinal Brush Border Glycohydrolases: Structure, Function, and Development
van Beers, E. H., Büller, H. A., Grand, R. J., Einerhand, A. W. C., & Dekker, J. W. T. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509085143 · Cited by 164
Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.
Bhargava, V., Kell, D., van de Rijn, M., & Warnke, R. A. (1994) · PubMed Central · Cited by 155
Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski, S., Bodrug, S., Gascoyne, R. D., Berean, K. W., Krajewska, M., & Reed, J. C. (1994) · PubMed Central · Cited by 153
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995) · Circulation Research · doi:10.1161/01.res.77.2.266 · Cited by 152
Apoptotic detection methods — from morphology to gene
OTSUKI, Y., Li, Z., & SHIBATA, M. (2003) · Progress in Histochemistry and Cytochemistry · doi:10.1016/s0079-6336(03)80002-5 · Cited by 153
Bcl-2 expression in normal endometrium during the menstrual cycle.
Gompel, A., Sabourin, J., Martin, A., et al. (1994) · PubMed · Cited by 149
Apoptosis and Programmed Cell Death in Health and Disease
Vermes, I., & Haanen, C. (1994) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60336-4 · Cited by 148
INDUCTION OF PROSTATE APOPTOSIS BY DOXAZOSIN IN BENIGN PROSTATIC HYPERPLASIA
Kyprianou, N., Litvak, J. P., Borkowski, A., et al. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63162-8 · Cited by 146
Choi, M. S. K., Boise, L., GOTTSCHALK, A. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250533 · Cited by 146
Yan, W. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00257-4 · Cited by 145
Strasser, A., Harris, A. W., von Boehmer, H., & Cory, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1376 · Cited by 144
Silvestrini, R., Benini, E., Veneroni, S., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1604 · Cited by 145
A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis
Arvelo, M. B., Cooper, J. T., Longo, C., Daniel, S., Grey, S. T., Mahiou, J., Czismadia, E., Abu-Jawdeh, G., & Ferran, C. (2002) · Hepatology · doi:10.1053/jhep.2002.31309 · Cited by 147
Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers
Smith, K. G. C., Weiss, U., Rajewsky, K., Nossal, G. J. V., & Tarlinton, D. M. (1994) · Immunity · doi:10.1016/s1074-7613(94)80022-7 · Cited by 142
“The exceptions are B cells in the apical light zone, where apoptosis is less prominent and where selection for high affinity B cells is thought to occur (Hockenbery et al., 1991).”
BackgroundA1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation
Lin, E., Orlofsky, A., Wang, H., et al. (1996) · Blood · doi:10.1182/blood.v87.3.983.bloodjournal873983 · Cited by 143
Follicular Dendritic Cells and Germinal Centers
Liu, Y.-J., Grouard, G., de BOUTEILLER, O., et al. (1996) · International review of cytology · doi:10.1016/s0074-7696(08)62508-5 · Cited by 141
Programmed cell death by bcl‐2‐dependent and independent mechanisms in B lymphoma cells.
Cuende, E., Alés-Martínez, J. E., Ding, L.-Y., et al. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05799.x · Cited by 141
Gonadal cell apoptosis: hormone-regulated cell demise
Billig, H. (1996) · Human Reproduction Update · doi:10.1093/humupd/2.2.103 · Cited by 138
“Although bcl-2 protein was not found in the human ovary (Hockenbery et al., 1991; Reed et al., 1991), a recent report has suggested that bcl-2 mRNA is expressed in rat ovaries but its level does not vary after gonadotrophin treatment.”
Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas
Karamitopoulou, E., Perentes, E., Tolnay, M., et al. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90224-6 · Cited by 138
Lisovsky, M. Y., Estrov, Z. E., Zhang, X., Consoli, U., Sanchez‐Williams, G., Snell, V., Munker, R., Goodacre, A., Vg, S., & Andreeff, M. (1996) · Blood · doi:10.1182/blood.v88.10.3987.bloodjournal88103987 · Cited by 136
Metadata
- Authors
- Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 6961-6965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52213
- OpenAlex
- W1970629830
- Semantic Scholar
- d825dc162ad208c572711f59c9aa1c7974e89492
- Cited by
- 1,252
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
- MeSH terms
- Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
